Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Return on Sales (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed Return on Sales for 3 consecutive years, with 0.29% as the latest value for Q4 2025.

  • Quarterly Return on Sales changed 0.0% to 0.29% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.09% through Dec 2025, up 8.0% year-over-year, with the annual reading at 0.09% for FY2025, 8.0% up from the prior year.
  • Return on Sales hit 0.29% in Q4 2025 for Immunocore Holdings, down from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.11% in Q3 2024 to a low of 0.36% in Q1 2023.
  • Historically, Return on Sales has averaged 0.16% across 3 years, with a median of 0.22% in 2023.
  • Biggest YoY gain for Return on Sales was 40bps in 2025; the steepest drop was -11bps in 2025.
  • Year by year, Return on Sales stood at 0.28% in 2023, then fell by -1bps to 0.28% in 2024, then fell by -2bps to 0.29% in 2025.
  • Business Quant data shows Return on Sales for IMCR at 0.29% in Q4 2025, 0.0% in Q3 2025, and 0.11% in Q2 2025.